DigitalOcean heads into its August 4 earnings report with a sharply changed setup from last week: the stock has cratered 17% in seven days to $117.02, reversing nearly all of its post-earnings gains, while the short-seller retreat that dominated last week's note has stalled and partially reversed.
The positioning picture has shifted meaningfully since July 8. Short interest climbed 7% over the week to 12.4% of the free float — roughly 11.4 million shares — reversing a month-long unwind and returning to levels last seen in late June. That said, the borrow market is not flashing distress. Cost to borrow sits at a negligible 0.42%, barely changed from last week's 0.46%, and availability is wide open at 410% — meaning the lending pool holds more than four shares available for every one currently shorted. Conditions are far looser than the tighter 260% availability that prevailed in mid-June. The short score has edged up to 56.1 from 54.8 a week ago, consistent with modest rebuilding rather than a fresh offensive push. Shorts are adding back positions into weakness, but the lending market suggests they face no friction in doing so.
Options are telling a contrarian story, and that divergence is the most striking setup this week. Call activity has overwhelmed puts, pushing the put/call ratio down to 0.60 — two standard deviations below its 20-day average of 0.80. That is the most aggressively bullish options skew in the past year, near the 52-week low of 0.31, and it stands in direct contrast to the short rebuilding. Options traders are treating the selloff as a buying opportunity; short sellers are treating it as confirmation. Both camps are pressing their views simultaneously, making August 4 the clearest referee.
The analyst community is broadly on the bull side of that debate, though with nuance. Most coverage carries Buy or Overweight ratings, with consensus targets clustered in the $180–$200 range — Canaccord and Keybanc both sit at $200, Citi raised to $185, and Barclays nudged up to $184. The outlier is UBS, which cut its target from $175 to $155 last week while keeping a Neutral rating — the only firm moving in the direction of the stock's recent price action. At the current $117, the mean Street target of $177 implies roughly 50% upside, a gap wide enough to suggest the selloff has outrun the fundamentals in the eyes of most analysts. EPS momentum factor scores rank in the 87th–89th percentile over 30 and 90 days, pointing to a string of estimate beats. The bear case centres on valuation: even after the selloff the P/E sits near 76x, the EV/EBITDA at 23x, and critics flag dependence on high-value AI customers whose growth trajectory remains uncertain.
The institutional inflow story from last week deserves a note of caution. BlackRock added nearly 2.8 million shares through June 30, JPMorgan built a fresh position of 4.5 million shares, and Wellington added 2.4 million. Those flows preceded the current decline, and it is worth watching whether they hold or trim into further weakness. On the insider side, both the CEO and CFO sold heavily at $155–$170 in late May and early June — prices well above current levels — which adds an uncomfortable footnote to the bull case, even if the trades were likely pre-planned.
Close peer APLD fell 18% on the week, broadly matching DOCN's move, while AKAM dropped 8% and TWLO lost 5% — confirming that the selloff is not purely idiosyncratic, but DOCN is absorbing more damage than most. With earnings on August 4 and two competing sets of conviction traders now pulling in opposite directions, the focus will be squarely on whether AI-driven revenue growth has held up through the quarter — and whether management's tone on enterprise customer expansion can close the gap between $117 and $177.
See the live data behind this article on ORTEX.
Open DOCN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
